NeOnc Targets Brain Cancer Trial Expansion Across 30 Hospitals
NeOnc targets a trial expansion involving 500 patients across 30 hospitals in three countries.
NeOnc targets a trial expansion involving 500 patients across 30 hospitals in three countries.